Brigitta C Brott Selected Research

gadolinium N- (2- butyryloxyethyl)- N'- (2- ethyloxyethyl)- N,N'- bis(N'',N''- bis(carboxymethyl)acetamido)- 1,2- ethanediamine

2/2012	Acute infarct selective MRI contrast agent.
4/2010	Differentiation of acute and four-week old myocardial infarct with Gd(ABE-DTTA)-enhanced CMR.
12/2008	Head-to-head comparison between delayed enhancement and percent infarct mapping for assessment of myocardial infarct size in a canine model.
7/2007	In vivo myocardial tissue kinetics of Gd(ABE-DTTA), a tissue-persistent contrast agent.
6/2007	Equilibrium signal intensity mapping, an MRI method for fast mapping of longitudinal relaxation rates and for image enhancement.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Brigitta C Brott Research Topics

Disease

16	Myocardial Infarction 12/2019 - 09/2003
9	Infarction (Infarctions) 03/2013 - 07/2007
6	Thrombosis (Thrombus) 01/2021 - 02/2009
5	Inflammation (Inflammations) 05/2022 - 01/2010
5	Hemorrhage 01/2021 - 09/2002
5	Acute Coronary Syndrome 12/2019 - 11/2003
4	Pathologic Constriction (Stenosis) 04/2011 - 11/2003
3	Hyperplasia 01/2022 - 01/2007
3	Fatigue 04/2013 - 10/2010
2	Obesity 05/2022 - 05/2015
2	Atherosclerosis 01/2021 - 04/2011
2	Diabetes Mellitus 11/2019 - 01/2011
2	Cicatrix (Scar) 01/2018 - 02/2012
2	Stroke (Strokes) 01/2018 - 01/2011
2	Necrosis 01/2018 - 04/2010
2	ST Elevation Myocardial Infarction 10/2013 - 06/2009
1	Insulin Resistance 05/2022
1	Body Weight (Weight, Body) 05/2022
1	Vascular Remodeling 01/2022
1	Arteriovenous Fistula 01/2022
1	Wounds and Injuries (Trauma) 05/2020
1	Chronic Renal Insufficiency 11/2019
1	Edema (Dropsy) 01/2018
1	Tooth Discoloration 06/2015
1	Infections 06/2015
1	Myocardial Stunning (Stunned Myocardium) 02/2015
1	Acute Kidney Injury (Acute Renal Failure) 11/2014
1	Coronary Aneurysm (Aneurysm, Coronary) 05/2013
1	False Aneurysm (Pseudoaneurysm) 05/2013
1	Stress Fractures (Stress Fracture) 04/2013
1	Vascular Calcification 01/2012
1	Vascular Diseases (Vascular Disease) 04/2011
1	Neointima 10/2008
1	Autolysis 10/2008
1	Spasm (Spasms) 12/2006
1	Coronary Vasospasm (Coronary Artery Vasospasm) 12/2006

Drug/Important Bio-Agent (IBA)

5	Contrast MediaIBA 01/2021 - 01/2006
5	Gadolinium DTPA (Magnevist)FDA Link 02/2012 - 12/2008
5	gadolinium N- (2- butyryloxyethyl)- N'- (2- ethyloxyethyl)- N,N'- bis(N'',N''- bis(carboxymethyl)acetamido)- 1,2- ethanediamineIBA 02/2012 - 06/2007
3	Clopidogrel (Plavix)FDA Link 12/2019 - 06/2009
3	MetalsIBA 04/2015 - 10/2008
3	triphenyltetrazoliumIBA 02/2012 - 04/2010
3	Eosine Yellowish-(YS) (Eosin)IBA 06/2011 - 01/2008
3	Hematoxylin (Haematoxylon)IBA 06/2011 - 01/2008
2	Nitric Oxide (Nitrogen Monoxide)FDA Link 05/2022 - 01/2022
2	LipidsIBA 05/2022 - 01/2021
2	TicagrelorIBA 12/2019 - 06/2017
2	Eptifibatide (Integrilin)FDA Link 12/2019 - 06/2017
2	GadoliniumIBA 01/2018 - 05/2012
2	Glycoproteins (Glycoprotein)IBA 06/2017 - 02/2009
2	IonsIBA 04/2013 - 01/2010
2	Prasugrel Hydrochloride FDA Link 01/2011 - 06/2009
1	Glucose (Dextrose)FDA LinkGeneric 05/2022
1	LeptinIBA 05/2022
1	Peptides (Polypeptides)IBA 05/2022
1	Insulin (Novolin)FDA Link 05/2022
1	Triglycerides (Triacylglycerol)IBA 05/2022
1	Nitric Oxide Synthase Type III (Endothelial Nitric Oxide Synthase)IBA 01/2022
1	Hemostatics (Antihemorrhagics)IBA 05/2020
1	GelsIBA 05/2020
1	Fibrinogen (Factor I)FDA Link 05/2020
1	Blood Coagulation Factors (Coagulation Factor)IBA 05/2020
1	Polymethyl Methacrylate (Sol)IBA 05/2020
1	TroponinIBA 12/2019
1	Hemoglobins (Hemoglobin)IBA 12/2019
1	omega-Chloroacetophenone (Mace)IBA 11/2019
1	Tirofiban (Aggrastat)FDA Link 06/2017
1	Anti-Bacterial Agents (Antibiotics)IBA 06/2015
1	Glucagon-Like Peptide 1 (GLP 1)IBA 02/2015
1	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 11/2014
1	Abciximab (ReoPro)FDA Link 10/2013
1	Dexfenfluramine (Redux)IBA 10/2013
1	Biological ProductsIBA 10/2010
1	CollagenIBA 04/2010
1	Stainless Steel (Steel, Stainless)IBA 01/2010
1	AlloysIBA 01/2010
1	Reactive Oxygen Species (Oxygen Radicals)IBA 01/2010
1	ElementsIBA 10/2008
1	ChloridesIBA 01/2008
1	Isoflurane FDA LinkGeneric 01/2006
1	nitinolIBA 08/2005
1	Phenobarbital (Luminal)FDA Link 08/2005
1	Low-Molecular-Weight Heparin (Heparin, Low Molecular Weight)IBA 11/2003
1	Heparin (Liquaemin)FDA LinkGeneric 09/2002

Therapy/Procedure

12	Stents 03/2016 - 08/2005
9	Percutaneous Coronary Intervention 12/2019 - 09/2002
7	Therapeutics 01/2021 - 01/2011
3	Drug-Eluting Stents 04/2015 - 12/2006
2	Renal Dialysis (Hemodialysis) 01/2022 - 01/2007
1	Microspheres (Microsphere) 03/2013
1	Drug Therapy (Chemotherapy) 04/2011
1	Aftercare (After-Treatment) 10/2008
1	Brachytherapy 10/2008
1	Catheters 07/2007
1	Anesthesia 01/2006
1	Patient Readmission 09/2003